Drawing for STANDIGM

USPTO serial 79287197

STANDIGM

Reviewed by CopyMark Law Group

Reg. 6465638Status 700Renewal
Filing date
Status date
Registration date
Aug 31, 2021
Examiner
FRUM MILONE, MARCIE R
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with STANDIGM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yoon S. Ham

Yoon S. Ham Hauptman Ham, LLP2318 Mill Road,Suite 1400Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005Preparations for treatment of hepatitis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; cardiovascular pharmaceutical preparations; dietary supplements; pharmaceutical preparations for the treatment of neurodevelopmental disorder; drugs for medical purposes in the nature of drug delivery agents in the form of tablets, capsules, powders, liquids, creams that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes, namely, for hepatitis, non-alcoholic fatty liver disease (NAFLD), osteoporosis, diabetes, Parkinson's disease, tuberculosis, Rheumatoid arthritis, autism, atopic dermatitis, cancer, skin diseases, central nervous system (CNS) diseases, infectious diseases, neurodegenerative diseases, mitochondrial diseases, neurodevelopmental disorders, cardiovascular disorders, inflammatory diseases, autoimmune disorders, and liver disease; pharmaceutical compositions in the nature of pharmaceutical preparations for the prevention and treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), osteoporosis, diabetes, Parkinson's disease, tuberculosis, Rheumatoid arthritis, autism, atopic dermatitis, cancer, skin diseases, central nervous system (CNS) diseases, infectious diseases, neurodegenerative diseases, mitochondrial diseases, neurodevelopmental disorders, cardiovascular disorders, inflammatory diseases, autoimmune disorders, and liver disease; pharmaceuticals in the nature of pharmaceutical preparations for hepatitis, non-alcoholic fatty liver disease (NAFLD), osteoporosis, diabetes, Parkinson's disease, tuberculosis, Rheumatoid arthritis, autism, atopic dermatitis, cancer, skin diseases, central nervous system (CNS) diseases, infectious diseases, neurodegenerative diseases, mitochondrial diseases, neurodevelopmental disorders, cardiovascular disorders, inflammatory diseases, autoimmune disorders, and liver disease; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for diagnosis in the nature of pharmaceutical preparations for hepatitis, non-alcoholic fatty liver disease (NAFLD), osteoporosis, diabetes, Parkinson's disease, tuberculosis, Rheumatoid arthritis, autism, atopic dermatitis, cancer, skin diseases, central nervous system (CNS) diseases, infectious diseases, neurodegenerative diseases, mitochondrial diseases, neurodevelopmental disorders, cardiovascular disorders, inflammatory diseases, autoimmune disorders, and liver disease; pharmaceutical preparations for the treatment of Parkinson's disease; anti-tuberculous preparations; anti-cancer preparationsACTIVE—
009Downloadable computer software for data collection, data analysis, data storing, data mining, data generation, and machine learning in the fields of public health and healthcare; downloadable computer software for facilitating research by collecting, analyzing, storing, mining, generating the data and learning machine in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; downloadable computer databases in the fields of scientific, medical, medicines, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; pre-recorded magnetic data carriers containing information, except computer software, in the fields of scientific, medical, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; pre-recorded computer discs containing information in the fields of scientific, medical, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; computer software downloadable from global computer information networks for data collection, data analysis, data storing, data mining, data generation or machine learning in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; computer software applications, downloadable, for mobile phones, portable media players and handheld computers namely, software for data collection, data analysis, data storing, data mining, data generation and machine learning in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; downloadable cloud computing software for use in data collection, data analysis, data storing, data mining, data generation and machine learning in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; downloadable computer software for data processing for use in in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; downloadable software for use in database management; downloadable computer application software for database management for use in in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; downloadable computer software for digital information and data access for use in in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; downloadable computer software for data analyzing purposes in the field of medical and biotechnology using algorithm for deep learning; downloadable computer software for simulating drug development; downloadable computer software for data collection, data analysis, data storing, data mining, data generation, and machine learning in the field of drug discovery and drug development; downloadable computer software for application and database integration; downloadable computer software for analyzing medical diagnosis information; downloadable software for services using artificial intelligence for data collection, data analysis, data storing, data mining, data generation, and machine learning in the field of drug discovery and drug development; downloadable artificial intelligence software for data collection, data analysis, data storing, data mining, data generation, and machine learning in the field of drug discovery and drug development; downloadable software for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable software for analytics for clinical trial data for use in the field of drug discovery and drug development; downloadable computer software for creating searchable databases of information and data for use in the field of drug discovery and drug developmentACTIVE—
035Retail store services featuring pre-recorded magnetic data carriers containing databases and information in the fields of scientific, medical, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; retail store services featuring pre-recorded computer discs containing databases and information in the fields of scientific, medical, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; retail store services featuring computer software for facilitating research in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; retail store services featuring computer software for data processing; data processing services; business data analysis; business research; commercial business management analyses including business management analysis of data on health and of biomedical research and clinical trial data; import-export agency services; retail store services featuring computer software for simulating drug discovery; providing commercial business information relating to drug discovery; retail store services featuring books in the field of drug discovery; business consultation in the field of marketing activities around the launching of drug discovery; retail store services featuring printed periodicals in the medical field; retail store services featuring drugs for the prevention and treatment of cancer; retail store services featuring medical reagents, namely, chemical test reagents; consultation services in the field of company, business sector and industry data and research, particularly documentation business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; consultation services in the field of company, business sector and industry data and research, particularly business consultancy services regarding the analysis of statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; consultation services in the field of company, business sector and industry data and research, particularly professional business consultancy services regarding the analysis of statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; retail store services featuring artificial intelligence software; retail store services featuring medicines for human purposes; systemization of information into computer databases; retail store services featuring pharmaceutical preparations for diagnosis; systematization and compilation of data in computer databases, particularly compilation of information in computer databases for research and analysis in the fields of biomedicine and clinical trials; statistical analyses being statistical evaluations of marketing data on health and on biomedical research and clinical trial dataACTIVE—
044Consulting services in the field of health; providing health information; provision of medical information from a website relating to the diagnosis of cancer, oncological disorders, autoimmune disorders, inflammatory disorders, hematological disorders and dermatological disorders; provision of medical information from a website relating to the treatment of cancer, oncological disorders, autoimmune disorders, inflammatory disorders, hematological disorders and dermatological disorders; providing medical information, medical consultancy and medical advisory services in the field of pharmaceutical products; healthcare consulting services in the field of pharmaceutical and medical products; healthcare advisory services relating to pharmaceuticals; medical analysis services for human biodata for medical purposes; medical analysis services for the diagnosis of cancer; medical consultations; provision of medical services by health care professionals via the internet or telecommunication networks; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing medical information, medical consultancy and medical advisory services in the field of medical products; medical information; medical diagnostic testing and analysis services; provision of medical products information; medical services, namely, medical diagnosis of conditions of the human body; medical testing for diagnostic or treatment purposes; provision of healthcare information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, disorders and pathologiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 31, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 15, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 27, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 7, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 7, 2022FIMPFINAL DISPOSITION PROCESSED—
Nov 30, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 31, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 15, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 15, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 7, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2021XAECEXAMINER'S AMENDMENT ENTERED—
May 7, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 7, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
May 7, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
May 5, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 5, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 5, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 1, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 19, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 19, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 19, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 19, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 3, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 14, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 14, 2020RFRRREFUSAL PROCESSED BY MPU—
Aug 19, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 17, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 27, 2020DOCKASSIGNED TO EXAMINER—
Jun 27, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 23, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 19, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 11, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance